VSL#3: An analysis of basic and clinical contributions in probiotic therapeutics

Gastroenterology Clinics of North America

Volumn 34, Issue 3, 2005, Pages 499-513

  Gionchetti, Paolo ^a   Lammers, Karen M ^a   Rizzello, Fernando ^a   Campieri, Massimo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; CIPROFLOXACIN; ESCHERICHIA COLI PROTEIN; MESALAZINE; METRONIDAZOLE; PROBIOTIC AGENT; RIFAXIMIN; SALAZOSULFAPYRIDINE;

BACTERIAL FLORA; BACTERIAL TRANSLOCATION; CROHN DISEASE; ENTERITIS; GASTROINTESTINAL TRACT; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; ILEITIS; NONHUMAN; REVIEW; ULCERATIVE COLITIS;

CLINICAL TRIALS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; PROBIOTICS;

EID: 23244454111     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2005.05.003     Document Type: Review

References (55)

1. G.L. Simon, and S.L. Gorbach Intestinal flora in health and disease Gastroenterology 86 1984 174 193
2. F. Guarner, and J.R. Malagelada Gut flora in health and disease Lancet 361 2003 512 519
3. G.W. Tannock Probiotics and prebiotics - where are we going? 2002 Caister Academic Press Wymondham, Norfolk, United Kingdom p. 1-39
4. A. Fasano, and J.P. Nataro Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins Adv Drug Deliv Rev 56 2004 795 807
5. M. Tollin, P. Bergman, and T. Svenberg Antimicrobial peptides in the first line defense of human colon mucosa Peptides 24 2003 523 530
6. K. Fellermann, and E.F. Stange Defensinsinnate - immunity at the epithelial frontier Eur J Gastroenterol Hepatol 13 2001 771 776
7. M. Goke, and D.K. Podolsky Regulation of the mucosal epithelial barrier Baillieres Clin Gastroenterol 10 1996 393 405
8. A.M. Mowat Anatomical basis of tolerance and immunity to intestinal antigens Nat Rev Immunol 3 2003 331 341
9. E. Cario, D. Brown, and M. McKee Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium Am J Pathol 160 2002 165 173
10. A.T. Gewirtz, T.A. Navas, and S. Lyons Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression J Immunol 167 2001 1882 1885
11. S.A. Radema, S.J. van Deventer, and A. Cerami Interleukin 1 beta is expressed predominantly by enterocytes in experimental colitis Gastroenterology 100 1991 1180 1186
12. S.K. Yang, L. Eckmann, and A. Panja Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells Gastroenterology 113 1997 1214 1223
13. M. Baggiolini Chemokines in pathology and medicine J Intern Med 250 2001 91 104
14. S.V. Sitaraman, D. Merlin, and L. Wang Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6 J Clin Invest 107 2001 861 869
15. T. Shibahara, J.N. Wilcox, and T. Couse Characterization of epithelial chemoattractants for human intestinal intraepithelial lymphocytes Gastroenterology 120 2001 60 70
16. M.B. Dwinell, N. Lugering, and L. Eckmann Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells Gastroenterology 120 2001 49 59
17. H.D. Janowitz, E.C. Croen, and D.B. Sachar The role of the fecal stream in Crohn's disease: an historical and analytic review Inflamm Bowel Dis 4 1998 29 39
18. L. Sutherland, J. Singleton, and J. Sessions Double blind, placebo controlled trial of metronidazole in Crohn's disease Gut 32 1991 1071 1075
19. G.R. D'Haens, K. Geboes, and M. Peeters Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum Gastroenterology 114 1998 262 267
20. A. Macpherson, U.Y. Khoo, and I. Forgacs Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria Gut 38 1996 365 375
21. C.O. Elson, R.B. Sartor, and G.S. Tennyson Experimental models of inflammatory bowel disease Gastroenterology 109 1995 1344 1367
22. M. Campieri, and P. Gionchetti Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative? Gastroenterology 116 1999 1246 1249
23. E. Metchnikoff The prolongation of life; Optimistic studies Mitchell 1907 William Heinemann London 161 183
24. H. Tissier Recherches sur la flore intestinale des nourissons (etat normal et pathologique) 1906 University of Paris Paris
25. D.M. Lilly, and R.H. Stillwell Probiotics: growth-promoting factors produced by microorganisms Science 147 1965 747 748
26. F. Guarner, and G. Schaafsma Probiotics Int J Food Microbiology 39 1998 237 238
27. O. Karimi, and A.S. Pena Probiotics: isolated bacteria strain or mixtures of different strains? Two different approaches in the use of probiotics as therapeutics Drugs Today (Barc) 39 2003 565 597
28. S. Salminen, A. von Wright, and L. Morelli Demonstration of safety of probiotics-a review Int J Food Microbiol 44 1998 93 106
29. F. Shanahan Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm Bowel Dis 6 2000 107 115
30. O. Shibolet, F. Karmeli, and R. Eliakim Variable response to probiotics in two models of experimental colitis in rats Inflamm Bowel Des 8 2002 399 408
31. K. Madsen, A. Cornish, and P. Soper Probiotic bacteria enhance murine and human intestinal epithelial barrier function Gastroenterology 121 2001 580 591
32. P. Gionchetti, F. Rizzello, and U. Helwig Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial Gastroenterology 124 2003 1202 1209
33. K.M. Lammers, A. Vergopoulos, and N. Babel Probiotic therapy in the prevention of pouchitis onset: decreased, interleukin-1beta, interleukin-8, and interferon-gamma expression Inflamm Bowel Dis 11 2005 447 454
34. S. Ulisse, P. Gionchetti, and S. D'Alo Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment Am J Gastroenterol 96 2001 2691 2699
35. K.M. Lammers, U. Helwig, and E. Swennen Effect of probiotic strains on interleukin 8 production by HT29/19A cells Am J Gastroenterol 97 2002 1182 1186
36. J.M. Otte, and D.K. Podolsky Functional modulation of enterocytes by gram-positive and gram-negative microorganisms Am J Physiol Gastrointest Liver Physiol 286 4 2004 G613 G626
37. E.O. Petrof, K. Kojima, and M.J. Ropeleski Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition Gastroenterology 127 2004 1474 1487
38. D.M. Klinman, A.K. Yi, and S.L. Beaucage CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma Proc Natl Acad Sci U S A 93 1996 2879 2883
39. A.M. Krieg, A.K. Yi, and S. Matson CpG motifs in bacterial DNA trigger direct B-cell activation Nature 374 1995 546 549
40. D. Rachmilewitz, K. Katakura, and F. Karmeli Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis Gastroenterology 126 2004 520 528
41. H. Hemmi, O. Takeuchi, and T. Kawai A Toll-like receptor recognizes bacterial DNA Nature 408 2000 740 745
42. H. Jijon, J. Backer, and H. Diaz DNA from probiotic bacteria modulates murine and human epithelial and immune function Gastroenterology 126 2004 1358 1373
43. K.M. Lammers, P. Brigidi, and B. Vitali Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells FEMS Immunol Med Microbiol 38 2003 165 172
44. K.M. Lammers, A.L. Hart, and P. Brigidi DNA derived from probiotic bacteria modulates human dendritic cell phenotype and function Gastroenterology Suppl 2004 A517
45. A.L. Hart, K. Lammers, and P. Brigidi Modulation of human dendritic cell phenotype and function by probiotic bacteria Gut 53 2004 1602 1609
46. M. Drakes, T. Blanchard, and S. Czinn Bacterial probiotic modulation of dendritic cells Infect Immun 72 2004 3299 3309
47. H. Schmitz, C. Barmeyer, and H. Fromm Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis Gastroenterology 116 1999 301 309
48. D.R. Mack, S. Michail, and S. Wei Probiotics inhibit enteropathogenic E coli adherence in vitro by inducing intestinal mucin gene expression Am J Physiol 276 1999 G941 G950
49. M.F. Bernet, D. Brassart, and J.R. Neeser Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria Gut 35 1994 483 489
50. L.E. Willemsen, M.A. Koetsier, and S.J. van Deventer Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts Gut 52 2003 1442 1447
51. A. Venturi, P. Gionchetti, and F. Rizzello Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis Aliment Pharmacol Ther 13 1999 1103 1108
52. R.N. Fedorak, P. Gionchetti, and M. Campieri VSL#3 probiotic mixture induces remission in patients with active ulcerative colitis Gastroenterology 124 2003 A377
53. P. Gionchetti, F. Rizzello, and A. Venturi Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial Gastroenterology 119 2000 305 309
54. T. Mimura, F. Rizzello, and U. Helwig Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis Gut 53 2004 108 114
55. P. Gionchetti, C. Amadini, and F. Rizzello Probiotics for the treatment of postoperative complications following intestinal surgery Best Pract Res Clin Gastroenterol 17 2003 821 831